PeptideDB

HIF1-IN-3 333314-79-7

HIF1-IN-3 333314-79-7

CAS No.: 333314-79-7

HIF1-IN-3 (compound F4) is a potent inhibitor of HIF1 with EC50 of 0.9 μM. HIF1-IN-3 could be used in anti-cancer resea
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

HIF1-IN-3 (compound F4) is a potent inhibitor of HIF1 with EC50 of 0.9 μM. HIF1-IN-3 could be used in anti-cancer research.

Physicochemical Properties


Molecular Formula C26H24N2O3
Molecular Weight 412.48
Exact Mass 412.178
CAS # 333314-79-7
PubChem CID 2930221
Appearance Light yellow to yellow solid powder
LogP 5.1
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 7
Heavy Atom Count 31
Complexity 557
Defined Atom Stereocenter Count 0
SMILES

C1C=CC(CCC(NC(C2C=CC(OC)=CC=2)C2=C(C3N=CC=CC=3C=C2)O)=O)=CC=1

InChi Key RFCCQJJHFAITGH-UHFFFAOYSA-N
InChi Code

InChI=1S/C26H24N2O3/c1-31-21-13-10-20(11-14-21)24(28-23(29)16-9-18-6-3-2-4-7-18)22-15-12-19-8-5-17-27-25(19)26(22)30/h2-8,10-15,17,24,30H,9,16H2,1H3,(H,28,29)
Chemical Name

N-[(8-hydroxyquinolin-7-yl)-(4-methoxyphenyl)methyl]-3-phenylpropanamide
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Structure-activity relationship for branched oxyquinoline HIF activators: Effect of modifications to phenylacetamide "tail". Biochimie. 2017;133:74-79.


Solubility Data


Solubility (In Vitro) DMSO : ~125 mg/mL (~303.04 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (5.04 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (5.04 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.4244 mL 12.1218 mL 24.2436 mL
5 mM 0.4849 mL 2.4244 mL 4.8487 mL
10 mM 0.2424 mL 1.2122 mL 2.4244 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.